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RÉDUCTION DES TROUBLES DE CONDUCTION ET 
DES ARYTHMIES VENTRICULAIRES PAR UN IEC DANS 
UN MODÈLE MURIN D’INSUFFISANCE CARDIAQUE
S. ZALVIDEA 1, C. CASSAN 1, J. THIREAU 1, I. SJAASTAD 2, 
J.-L. PASQUIÉ 1, F. AIMOND 1, S. RICHARD 1
1 Inserm U 637, Montpellier, France
2 IEMR, Oslo, Norway
Les effets béné ques des inhibiteurs de l’enzyme de conversion de 
l’angiotensine (IEC) sur la mortalité, la morbidité et la qualité de vie 
des patients en insuf sance cardiaque ont largement été démontrés. 
Toutefois, le rôle des IEC sur l’incidence des arythmies ventriculaires 
n’a pas été clairement établi. Le but de ce travail a été d’évaluer 
les effets du delapril (un IEC) sur les arythmies ventriculaires et les 
troubles de conduction dans un modèle murin d’infarctus du myocarde 
(IM).
Méthodes et Résultats — Des souris en insuf sance cardiaque, 
après ligature de la coronaire gauche (souris IM), ont été comparées 
à des souris contrôles. Les souris IM sont caractérisées par une 
hypertrophie cardiaque (échocardiographie) et une augmentation 
signi cative de la mortalité. Les analyses des coupes histologiques 
révèlent une augmentation de la  brose interstitielle associée à 
une augmentation des ARNm codants pour le collagène I et III. Les 
mesures électrophysiologiques in vivo (ECG de surface, explorations 
endocavitaires) montrent un allongement des intervalles QTc et QRS, 
une augmentation du nombre d’arythmies ventriculaires et des blocs 
atrio-ventriculaires (BAV), ainsi qu’une altération des intervalles Atrio-
Hissien (AH) et Hissien-Ventriculaire (HV). Les mesures réalisées en 
patch-clamp sur des cardiomyocytes ventriculaires isolés révèlent une 
hypertrophie cellulaire, une dépolarisation du potentiel de membrane 
et un allongement du potentiel d’action, en accord avec une diminution 
du courant recti ant entrant potassique de fond (Ik1).
Le traitement des souris IM avec une dose non-hypotensive (6 mg/kg/
jour) de delapril, 24 h après la chirurgie et ce, pendant 6 semaines : 
(i) améliore la survie (87 % chez les souris IM-delapril vs. 62 % chez les 
souris IM ; P < 0.05) ; (ii) diminue l’hypertrophie cardiaque, la  brose 
ainsi que les marqueurs biologiques associés ; (iii) corrige l’altération 
des intervalles QTc, QRS, AH et HV ; et réduit le nombre d’événements 
arythmiques ; et (iv) normalise les altérations électrophysiologiques 
cellulaires.
Conclusion — En conclusion, le delapril administré précocement 
réduit les arythmies ventriculaires et les troubles de conduction après 
un IM ; ceci sans modi cation de la pression artérielle. Ces béné ces et 
l’amélioration de la survie sont principalement liés à une prévention 
de la  brose cardiaque et du remodelage électrophysiologique 
cellulaire.
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ACTUAL DATA OF PATIENTS WITH WOLFF-
PARKINSON-WHITE SYNDROME AND WITH 
SPONTANEOUS LIFE-THREATENING ARRHYTHMIA
C. TATAR 1, B. BREMBILLA-PERROT 1
1 Cardiology, CHU de Brabois, Vandoeuvre-Lès-Nancy, France
Serious events were reported in Wolff-Parkinson-White syndrome 
(WPW). Male sex, young age, sport, septal accessory pathway (AP), 
short AP refractory period, atrial  brillation (AF) were reported as 
risk factors of sudden death (SD). The purpose of the study was to 
look for the predictors of adverse events in WPW.
Population — Adverse event occurred in 54 of 602 patients with 
a WPW (9 %) (group I). Other patients (group II) had syncope (61), 
tachycardias (285) or were asymptomatic (205).
Methods — Clinical and electrophysiological data were collected. 
WPW was considered at risk of SD when AF had shortest RR interval 
< 250 ms in control state (CS), < 200 ms with isoproterenol.
Results — In group I, event was resuscitated SD (5), syncopal AF 
requiring urgent treatment. Facilitating factors were heart disease 
(4), sport (4), stress (2), calcium inhibitors (3), post operative period 
(2), hyperthyroidism (1). Age was higher in group I (39±18) than II 
(34±16)**. Sex male was as frequent in groups I and II (65 %, 59 %). 
AP left lateral location was more frequent in group I (70 %) than 
II (37 %)***, posteroseptal location less frequent in group I than II 
(20 % vs 48 %)***. Re-entrant tachycardia was more frequent in group 
I (30 %) than in asymptomatic patients (12.5 %)**, but less frequent 
than in group II patients with tachycardia (80 %)***. AF was more 
frequent in group I (98 %) than in asymptomatic patients (23 %) or 
with tachycardia (16 %)***. Maximal rate conducted by AP was higher 
in group I than II in CS (264±43 b/min vs 186±58) or after isoproterenol 
(324±26 vs 238±66)**. Malignant form was more frequent in group I 
(92.5 %) than II (10 %)***.
Conclusions — risk factors of adverse event as the  rst manifestation 
of WPW have changed during the last years. Sport activity was 
rare but factors as drugs, post surgery were noted. Posteroseptal 
location was rare and left lateral location was the most frequent 
location. Age was relatively high and the women had risks similar 
to those of men.
G008
DECREASE OF INDUCTION OF VENTRICULAR 
FLUTTER AND FIBRILLATION AFTER MYOCARDIAL 
INFARCTION SINCE PRIMARY ANGIOPLASTY
B. AZMAN 1, N. SADOUL 1, H. BLANGY 1, B. BREMBILLA-PERROT 1
1 Cardiologie, CHU de Brabois, Vandœuvre-lès-Nancy, France
Programmed ventricular stimulation (PVS) is used to stratify the 
arrhythmic risk after myocardial infarction (MI). Monomorphic 
ventricular tachycardia <270 b/min (VT) is associated with high 
risk, but induction of ventricular  utter or  brillation (VF) has 
a discussed signi cance. Treatments have changed since the 
beginning of PVS. The purpose of the study was to look for the 
results of systematic PVS after MI between 1982 and 2008.
Methods — PVS was performed in 780 patients without syncope or 
ventricular arrhythmias, between 1982 and 2008, from 4 to 8 weeks 
after acute MI: 301 (group I) were studied between 1982-1989 ; 315 
(group II) between 1990-1999 and 164 (group III) between 2000-
2008. PVS used the same protocol (up to 3 extrastimuli in 2 sites 
of right ventricle).
Results — Clinical and electrophysiological data were similar in 
groups I and II but differed in group III: age was higher in group III 
(61±11 years) than in group I (56±11) and II (58±11) (p <0.002); left 
ventricular ejection fraction (LVEF) was lower in group III (36±11 %) 
than in group I (44±15), II (41±12) (p<0.05). PVS was as frequently 
negative in group III (58.5 %) than in group I (52 %), II (47 %). VT was 
induced as frequently in group III (26 %) than in group I (20 %), II 
(21.5 %). VF were less frequently induced in group III (15 %) than in 
group I (28.5 %) (p <0001) and II (29.5 %) (p<0.01). The changes were 
not related to beta blockers, similar in 3 groups (65 % in group I, 
68 % in group II, 72 % in group III) or ACE inhibitors introduced in 
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groups II (55 %), III (65 %). The changes could be related to primary 
angioplasty, systematic since 2000.
Conclusions — Induction of ventricular  utter or  brillation is 
actually rarer than in years 1985/2000. The decrease corresponded 
with the development of primary angioplasty and revascularization. 
The induction of monomorphic VT < 270 b/min has not changed 
although a lower LVEF in patients studied since 2000.
G009
REGULATION OF THE CARDIAC SODIUM CHANNEL 
NAV1.5 BY A MEMBER OF MAGUK PROTEINS: SAP97
S. PETITPREZ 1, A.-F. ZMOOS 1, S. HATEM 2, A. COULOMBE 2, 
H. ABRIEL 1
1 Département de Pharmacologie et Toxicologie, Université 
de Lausanne, Lausanne, Switzerland
2 Inserm U621, Université Pierre et Marie Curie-Paris6, 
Paris, France
Nav1.5 is the voltage-gated sodium channel that initiates the 
cardiac action potential. A precise regulation and localisation of 
Nav1.5 channels in cardiomyocytes is thus necessary for correct 
heart function. The three last amino-acids of Nav1.5 (SIV) 
constitute a PDZ-domain binding motif known to interact with the 
syntrophin-dystrophin complex and PDZ domains found in proteins 
of the MAGUK family. Among their multiple roles, MAGUK proteins 
can cluster proteins and localize them at the plasma membrane.
We investigated the interaction between SAP97, one cardiac 
MAGUK protein, and Nav1.5. We postulated that this interaction 
may be implicated in correct localisation, anchoring, turn-over 
and/or regulation of Nav1.5 biophysical properties.
Pull-down experiments performed with Nav1.5 C-terminus fusion 
proteins and human or mouse heart protein extracts revealed that 
the association between SAP97 and Nav1.5 depends on the PDZ-
domain binding motif of Nav1.5. This interaction was speci c for 
SAP97 and Nav1.5 as no pull-down could be detected with PSD95 
or ZO-1, two MAGUK proteins also expressed in human heart. The 
functional consequences of this interaction were studied via patch-
clamp experiments. Silencing of SAP97 reduced the whole-cell 
sodium current measured in HEK293 cells stably expressing Nav1.5 
channels without decreasing the total protein amount. In control 
or silenced HEK293 cells, sodium current produced by Nav1.5 δSIV 
channels was reduced compared to WT. Immunostainings on frozen 
mouse heart slices demonstrated the colocalisation of Nav1.5 
and dystrophin speci cally at lateral membranes, but not at the 
intercalated discs. The possible colocalisation of Nav1.5 and SAP97 
at the level of intercalated disks is currently investigated. This 
would support the hypothesis of the presence of two pools of Nav1.5 
channels: one targeted at lateral membranes by the syntrophin-
dystrophin complex, and another one targeted at intercalated discs 
by SAP97.
These  ndings strongly support the existence of an interaction 
between Nav1.5 and SAP97 in cardiac tissue. This interaction also 
depends on the presence of Nav1.5 PDZ-domain binding motif and 
may play a role in determining the channel density at the plasma 
membrane. Additional biochemistry, cytochemistry and biophysical 
experiments will allow us to further address this question.
G010
REGULATION OF VOLTAGE-DEPENDENT CALCIUM 
CHANNELS BY NEDD4-1
M. ALBESA 1, J.-S ROUGIER 2, H. ABRIEL 1, P. VIARD 2
1 Department of Pharmacology and Toxicology, University of 
Lausanne, Lausanne, Switzerland
2 Department of Neuroscience, Physiology and Pharmacology, 
University College London, London, United Kingdom
Calcium entry into excitable cells can be regulated by controlling both 
the activity of calcium channels and the amount of channels available 
at the plasma membrane. Little is known about their internalisation 
and degradation. One post-translational modi cation shown to 
be involved in membrane protein internalisation and subsequent 
degradation is the attachment of ubiquitin moieties by ubiquitin-
ligases. Previously, it has been shown that cardiac ion channels such 
as Nav1.5 and KCNQ1 are down-regulated by ubiquitin-ligases of the 
Nedd4 family. These regulations involve the interaction between the 
PY motif of the target channels and the WW motif of the ubiquitin-
ligases. Despite the absence of such PY motif in the cardiac voltage-
gated calcium channel Cav1.2, we investigated whether this channel 
could by regulated in the same manner than other cardiac channels as 
previously described.
We co-expressed, in HEK293 cells, L-type calcium channels and its 
two regulatory subunits Cavbeta and Cavalpha2delta1 together 
with ubiquitin-ligases, and examined by voltage-clamp whole-cell 
recordings the calcium current. We next determined by western 
blot and surface biotinylation assays the availability of the different 
subunits of calcium channels in total HEK293 lysates, and at the 
cell surface. Levels of ubiquitylation of the different subunits were 
assessed by pull-down GST-S5A and immunoprecipitation of Cav1.2 
and its subunits.
We found that co-expressing the ubiquitin-ligase Nedd4-1 signi cantly 
reduced Cav currents, and decreased Cavalpha and its subunit protein 
levels. This effect was Nedd4-1 speci c since none of the other 
members of the Nedd4 family we tested produced a similar effect. 
We also found that the effect of Nedd4-1 was dependent on the co-
expression of the Cavbeta subunit. No Nedd4-1-dependent increase in 
ubiquitylation of the Cavalpha protein was found ; and unexpectedly, 
the two regulating subunits Cavbeta and Cavalpha2delta1 were 
detected to be deubiquitylated upon Nedd4-1 co-expression.
Our data suggest that Nedd4-1 regulates the expression of Cav channels 
and its subunits by Nedd4-1 via an indirect mechanism constituting a 
new regulatory pathway to be determined. Further experiments will 
focus on the role of adrenergic receptors known to be ubiquitylated 
by Nedd4 and to bind to Cav1.2.
G011
INCIDENCE AND PROGNOSIS OF VENTRICULAR 
TACHYCARDIA IN APPARENTLY NORMAL SUBJECTS
J.-M. SELLAL 1, N. SADOUL 1, H. BLANGY 1, B. BREMBILLA-PERROT 1
1 Cardiology, CHU de Brabois, Vandœuvre-lès-Nancy, France
The prognosis of ventricular tachycardia (VT) is related to the 
presence of heart disease (HD). VT in patients without HD is 
considered as benign. However some sudden deaths were reported. 
The development of new methods as cardiac MRI has permitted 
to detect HD in some patients. The purpose of the study was to 
evaluate the incidence and prognosis of patients recruited since 30 
years for VT and without apparent HD with conventional methods.
